Asunto(s)
Enfermedad Coronaria/sangre , Enfermedad Coronaria/patología , Lengua/patología , Femenino , Humanos , MasculinoRESUMEN
BACKGROUND: Although the use of acupuncture anesthesia for open heart surgery, which was introduced in China four decades ago, has declined in recent years, there is a renewed interest in it in contemporary China due to the escalating medical costs associated with open heart surgery. This study was aimed to determine whether a combined acupuncture-medicine anesthesia (CAMA) strategy reduces early postoperative morbidity and medical costs in patients undergoing open heart operation under cardiopulmonary bypass. METHODS: From July 2006 to October 2010, CAMA was applied in 100 patients undergoing open heart surgery in comparison with another 100 patients under the conventional general anesthesia (GA). For all the CAMA patients, an abdominal breathing training program was practiced for the 3 consecutive days prior to operation. About 15 to 20 min prior to surgical incision, acupuncture needles were inserted into the bilateral points ZhongFu, LieQue, and XiMen. During operation, patients were kept on spontaneous breathing. Endotracheal intubation was not employed but only prepared as a standby. The narcotic drugs, fentanyl and midazolam, were intravenously injected but in very low doses as compared to GA. Open heart procedures were performed routinely in both groups. RESULTS: Compared with the GA patients, the CAMA patients had a less usage of narcotic drugs (p<0.001), less postoperative pulmonary infection (p<0.05), shorter stay in intensive care unit (p<0.05), and a lower medical cost (P<0.05). CONCLUSIONS: A combined acupuncture-medicine anesthesia strategy reduces the postoperative morbidity and medical costs in patients undergoing open heart surgery under cardiopulmonary bypass.
Asunto(s)
Analgesia por Acupuntura/métodos , Procedimientos Quirúrgicos Cardíacos/métodos , Complicaciones Posoperatorias/prevención & control , Músculos Abdominales/fisiología , Analgesia por Acupuntura/economía , Analgesia por Acupuntura/tendencias , Adolescente , Adulto , Anciano , Anestesia General/efectos adversos , Anestesia General/métodos , Procedimientos Quirúrgicos Cardíacos/economía , Procedimientos Quirúrgicos Cardíacos/tendencias , China/epidemiología , Terapia Combinada , Femenino , Humanos , Tiempo de Internación/economía , Tiempo de Internación/tendencias , Masculino , Persona de Mediana Edad , Narcóticos/administración & dosificación , Complicaciones Posoperatorias/economía , Complicaciones Posoperatorias/epidemiología , Adulto JovenAsunto(s)
Cirugía Bariátrica/efectos adversos , Obesidad Mórbida/cirugía , Selenio/deficiencia , Cardiomiopatías/sangre , Cardiomiopatías/tratamiento farmacológico , Cardiomiopatías/etiología , Suplementos Dietéticos , Infecciones por Enterovirus/sangre , Infecciones por Enterovirus/tratamiento farmacológico , Infecciones por Enterovirus/etiología , Humanos , Obesidad Mórbida/complicaciones , Selenio/sangre , Selenito de Sodio/uso terapéutico , Resultado del TratamientoAsunto(s)
Hierro de la Dieta/metabolismo , Té/metabolismo , Absorción , Animales , Disponibilidad Biológica , Humanos , Ratas , Té/efectos adversosRESUMEN
Danshen is one of the most versatile Chinese herbal drugs that have been used for hundred of years in the treatment of numerous ailments. Because of its properties of improving microcirculation, causing coronary vasodilatation, suppressing the formation of thromboxane, inhibiting platelet adhesion and aggregation, and protecting against myocardial ischemia, it is widely used either alone or in combination with other herbal ingredients for patients with coronary artery disease and other cardiovascular diseases, in both China and other countries including the United States. This article provides an overview of its history, pharmacology, pharmacokinetics, clinical applications, side effects, interactions with Western drugs, and future prospects in the management of cardiovascular diseases.